An American health and wellness cannabidiol (CBD) company is celebrating its new Canadian stock exchange listing.
Denver-based HempFusion today announced it would be celebrating its listing on the Toronto Stock Exchange (TSX) by “virtually” ringing the opening bell at 9:00 a.m. EST.
HempFusion already completed its $17,000,000 initial public offering and began trading on the TSX on January 6, 2021.
“It’s an honor to complete our initial public offering and listing on Canada’s most senior stock exchange,” says HempFusion co-founder and CEO Jason Mitchell N.D. “And we greatly appreciate the opportunity to ring the opening bell this morning.”
During the virtual ceremony, Dr. Mitchell was joined by senior management, the HempFusion board of directors, and other key HempFusion team members.
HempFusion currently sells products from its family of brands, including Probulin Probiotics and HF Labs, in approximately 4,000 retail locations across all 50 states.
On January 14, HempFusion announced its expansion into the European market through a distribution agreement with an extensive retail network.
The distributor, which is currently kept anonymous for competition reasons, has established relationships for HempFusion and Probulin products to be available through most retailers across Ireland.
Potential distribution points include Boots, Lloyds, Nourish, The Health Store, and other natural retailers representing more than 1,000 shops across Ireland.
